Catalyst Technology Improves Hydrogen Peroxide-Based Decontamination
The patented SKAN NANOX Catalysts enable higher efficiency breakdown of hydrogen peroxide at lower temperatures for shorter decontamination cycles.
The patented SKAN NANOX Catalysts were developed in cooperation with a Swiss university and engineered to enable higher efficiency breakdown of hydrogen peroxide at lower temperatures. The catalyst reduces the overall time and energy required for hydrogen peroxide-based decontamination and aeration, while positively impacting the effect on the environment.
The catalyst can be used in aseptic processing isolators, such as SKAN’s modular, small-scale Pharmaceutical Safety Isolator (PSI-L) with SARA material airlocks for conventional aseptic applications. The short decontamination cycle and the return air filter make it a universal, aseptic workspace for the production of aseptic and/or highly active pharmaceutical products.
Source: SKAN
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
